The Nasdaq Biotech Index rose 3.2% after successful large-scale trials of Moderna and MSD's melanoma vaccines.

Zhitongcaijing · 2d ago
The Nasdaq Biotech Index rose 3.2% after successful large-scale trials of Moderna and MSD's melanoma vaccines.